Why Moderna Could Be Worth $100 Billion Within 5 Years | The Motley Fool
The Motley Fool· 14 hours agoThere are only a dozen drugmakers in the world right now with market caps of $100 billion or more....
Some Moderna COVID-19 vaccine recipients have experienced delayed skin reactions following jab,...
Fox News· 7 hours agoDoctors in the letter detailed 12 cases of delayed skin reactions that appeared some four to 11 days...
Researchers urge greater awareness of delayed skin reactions to Moderna COVID-19 vaccine
Medical Xpress· 17 hours agoIn a letter to the editor published online in The New England Journal of Medicine (NEJM), the...
Doctors found a weird new coronavirus vaccine side effect that takes a week to appear
BGR· 5 hours agoSeveral coronavirus vaccine candidates have been authorized for emergency use around the world. Most...
Why Moderna Stock Is Sinking Again Today | The Motley Fool
The Motley Fool· 1 day agoShares of Moderna (NASDAQ:MRNA) were sinking 7.2% lower as of 12:03 p.m. EST on Wednesday. It marked...
Moderna Extends Gains as Jim Cramer Talks About Potential Cancer Vaccine
TheStreet.com· 6 days agoCramer, speaking on CNBC's Squawk on the Street program, said the developments were "pre-clinical" but nonetheless remarkable and are based on the drugmaker's messenger-RNA delivery techniques ...
Johnson & Johnson Coronavirus Vaccine Wins FDA Authorization
Motley Fool· 4 days agoIn contrast to the two shots required for both of the other FDA-authorized coronavirus vaccines --...
Moderna Stock May Still Be Undervalued by 30%, Says Analyst
TipRanks via Yahoo Finance· 3 days agoModerna (MRNA) has been one of the past year’s most successful stories. The change between the...
JNJ Stock: Avoid Johnson & Johnson Shares Like the Plague
InvestorPlace· 8 hours agoJohnson & Johnson (NYSE:JNJ) is in it for the long run. Let’s look at what’s happening off and on...
Moderna Misses Expectations But Remains Optimistic For Future Vaccine Rollout
Benzinga· 6 days agoModerna (NASDAQ: MRNA) saw its stock jump on Thursday despite mounting losses, after the COVID-19...